Impact of caspase-8 and PKA in regulating neutrophil-derived microparticle generation

Emily F Midura1, Priya S Prakash1, Bobby L Johnson1

  • 1Division of Research, Department of Surgery, University of Cincinnati College of Medicine, 231 Albert Sabin Way ML 0558, Cincinnati, OH 45267, USA.

Insights

Neutrophil-derived microparticles (NDMPs) play a role in sepsis inflammation. This study identified key molecular pathways, including caspase and MLCK activation, that regulate NDMP generation, offering potential therapeutic targets.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Medicine

Background:

  • Sepsis remains a leading cause of morbidity and mortality despite advances in treatment.
  • Microparticles (MPs), particularly neutrophil-derived MPs (NDMPs), are implicated in inflammatory processes and intercellular communication during sepsis.
  • Previous research has shown NDMPs can modulate immune cells, but the mechanisms of their generation are not fully understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms regulating the generation of neutrophil-derived microparticles (NDMPs).
  • To identify key signaling pathways involved in NDMP production.

Main Methods:

  • Neutrophils were recruited and activated using thioglycolate (TGA) in vivo and in vitro.
  • Investigated the roles of caspase pathways (intrinsic and extrinsic), cAMP-dependent PKA and Epac activation, and myosin light chain kinase (MLCK) in NDMP release.

Main Results:

  • Intra-peritoneal TGA administration increased NDMP accumulation.
  • NDMP generation was dependent on the extrinsic caspase apoptotic pathway (caspase 3 and 8).
  • NDMP production required cAMP activation of PKA (protein kinase A) and MLCK activation, but not Epac.

Conclusions:

  • The study delineates a molecular framework for NDMP generation.
  • Identified specific signaling pathways (extrinsic caspase, PKA, MLCK) crucial for NDMP release.
  • Findings provide insights into the inflammatory mechanisms of sepsis and potential targets for immunomodulatory therapies.